Derek Cole
Host, Investor Relations Advisory Solutions
Replay available
Longeveron Inc. (NASDAQ: LGVN) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.

Host, Investor Relations Advisory Solutions
Chief Executive Officer
Chief Medical Officer
Chief Technology Officer
Chief Financial Officer
Analyst, Roth Capital
Analyst, H.C. Wainwright
Analyst, Maxim Group
Watch the replay and follow the connected company analysis, news, and investor updates for Longeveron Inc..
WEBVTT 00:00:00.031 -- 00:00:04.397 Follow the formal presentation. Should anyone require operator assistance during the 00:00:04.397 -- 00:00:08.101 conference, please press star zero on your telephone keypad. 00:00:08.101 -- 00:00:10.244 As a reminder, this conference is being recorded. 00:00:10.244 -- 00:00:15.451 It is now my pleasure to introduce your host, Derek Cole of Investor Relations 00:00:15.451 -- 00:00:18.034 Advisory Solutions. Thank you. You may begin. 00:00:18.034 -- 00:00:22.880 Thank you, operator. Good afternoon, everyone, and thank you for joining us today to 00:00:22.880 -- 00:00:27.723 review Longevron's 2025 first quarter financial results and business updates. 00:00:27.723 -- 00:00:31.669 After the U.S. markets closed today, we issued a press release with financial results 00:00:31.669 -- 00:00:37.577 for Q1 2020, which can be found under the investor section of the Longevron website. 00:00:37.577 -- 00:00:42.844 On the call today are Wael Hashad, Chief Executive Officer, Joshua O'Hare, Co-Founder, 00:00:42.844 -- 00:00:47.591 Chief Science Officer and Chairman of the Board, Natalia Agafonova, Chief Medical Officer, 00:00:47.591 -- 00:00:52.818 Lisa Locklear, Chief Financial Officer, and Devin Blass, Chief Technology Officer. 00:00:52.818 -- 00:00:56.697 As a reminder, during this call, we will be making forward-looking statements. 00:00:56.697 -- 00:01:00.282 These statements are subject to certain risks and uncertainties that could cause actual 00:01:00.282 -- 00:01:03.167 results to differ materially from these statements. 00:01:03.167 -- 00:01:06.412 Any such statements should be considered in conjunction with cautionary statements in 00:01:06.412 -- 00:01:10.578 our press release and risk factors discussed in the company's filings with t...